Crown Castle (NYSE:CCI) Price Target Lowered to $90.00 at Jefferies Financial Group
Crown Castle (NYSE:CCI – Free Report) had its price target cut by Jefferies Financial Group from $102.00 to $90.00 in a research report released on Tuesday,MarketScreener reports. They currently have a hold rating on the real estate investment trust’s stock. Several other equities research analysts have also issued reports on the company. Wolfe Research raised […]
Dollarama (TSE:DOL) Price Target Raised to C$235.00 at Jefferies Financial Group
Dollarama (TSE:DOL – Get Free Report) had its price target hoisted by research analysts at Jefferies Financial Group from C$223.00 to C$235.00 in a research note issued to investors on Friday,BayStreet.CA reports. Jefferies Financial Group’s price objective indicates a potential upside of 16.93% from the stock’s previous close. Several other research firms have also recently […]
Raymond James Financial (NYSE:RJF) Price Target Raised to $196.00 at Bank of America
Raymond James Financial (NYSE:RJF – Get Free Report) had its target price boosted by equities research analysts at Bank of America from $194.00 to $196.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the financial services provider’s stock. Bank of America‘s target price suggests a potential […]
Duke Energy (NYSE:DUK) Price Target Cut to $126.00 by Analysts at Jefferies Financial Group
Duke Energy (NYSE:DUK – Get Free Report) had its target price decreased by analysts at Jefferies Financial Group from $138.00 to $126.00 in a research note issued on Monday,MarketScreener reports. The brokerage presently has a “hold” rating on the utilities provider’s stock. Jefferies Financial Group’s target price indicates a potential upside of 10.03% from the […]
Edwards Lifesciences (NYSE:EW) Price Target Raised to $100.00 at Royal Bank Of Canada
Edwards Lifesciences (NYSE:EW – Get Free Report) had its price target lifted by analysts at Royal Bank Of Canada from $95.00 to $100.00 in a research note issued on Friday,Benzinga reports. The brokerage currently has an “outperform” rating on the medical research company’s stock. Royal Bank Of Canada’s price objective would suggest a potential upside […]
last updated on 17 Dec 18:25